STOCK TITAN

PREAXIA HEALTH CARE PYMNT (PAXH) Financials

PAXH
FY2026 annual
Revenue $0 YoY not available
Net Income -$1.2M -1316.3% YoY
EPS (Diluted) -$0.03 YoY not available
Free Cash Flow -$443K -966.4% YoY
Source SEC Filings (10-K/10-Q) Latest period FY2026, ended May 31, 2026 Reported Currency USD FYE May

Newest figures come from the 10-K for FY2026, filed Sep 4, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the PAXH SEC filings page.

PREAXIA HEALTH CARE PYMNT (PAXH) reported $0 in revenue for fiscal year 2026. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI PAXH FY2026

The available FY2022 snapshot shows a liability-heavy balance sheet with almost no current-asset support for reported activity.

Reported revenue was $368K against just $259K of assets, while liabilities reached $2.1M; that combination indicates obligations vastly exceeded the reported resource base. The 0.0x current ratio adds a separate short-term constraint, showing that current assets were negligible relative to current liabilities.

Negative equity of -$2.1M and the 0.0x current ratio describe both a long-term balance-sheet deficit and immediate liquidity tightness, rather than simply low profitability.

Some figures from recent filings were inconsistent and were omitted from this summary.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Financial health score not available

PREAXIA HEALTH CARE PYMNT does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Earnings Quality No Cash Backing
N/A

PREAXIA HEALTH CARE PYMNT reported a net loss of $1.2M while operations used $121K of cash. With neither figure positive, the ratio between the two carries no quality signal.

Interest Coverage At Risk
N/A

PREAXIA HEALTH CARE PYMNT reported an operating loss of $993K against $326 in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.

Key Financial Metrics

Export CSV

Earnings & Revenue

EPS (Diluted)
-$0.01

PREAXIA HEALTH CARE PYMNT earned -$0.01 per diluted share (EPS) in Q4 2026.

Revenue

Not reported for Q4 2026.

EBITDA

Not reported for Q4 2026.

Net Income

Not reported for Q4 2026.

Cash & Balance Sheet

Free Cash Flow
-$126K
YoY-605.9%
QoQ+4.2%

PREAXIA HEALTH CARE PYMNT recorded an outflow of $126K in free cash flow in Q4 2026, representing a cash shortfall after capex. This represents a decrease of 605.9% from the same quarter a year earlier. Against the prior quarter it is up 4.2%.

Cash & Debt
$1K
QoQ-98.3%
5Y CAGR+90.5%

PREAXIA HEALTH CARE PYMNT held $1K in cash as of Q4 2026; long-term debt is not reported for that period.

Shares Outstanding
48M
QoQ+8.1%
5Y CAGR+19.6%
10Y CAGR+10.2%

PREAXIA HEALTH CARE PYMNT had 48M shares outstanding in Q4 2026. Against the prior quarter it is up 8.1%.

Dividends Per Share

Not reported for Q4 2026.

Margins & Returns

None of these metrics is reported for Q4 2026.

Capital Allocation

Capital Expenditures
$114K
QoQ-16.9%

PREAXIA HEALTH CARE PYMNT invested $114K in capex in Q4 2026, funding long-term assets and infrastructure. Against the prior quarter it is down 16.9%.

R&D Spending

Not reported for Q4 2026.

Share Buybacks

Not reported for Q4 2026.

PAXH Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

PAXH quarterly income statement
MetricQ4'2610-KQ3'2610-QQ2'2610-QQ1'2610-Q/AQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-Q/A
RevenueN/A$0$0$0N/A$0$0$0
R&D ExpensesN/A$0$0$391KN/A$0-100.0%$0-100.0%$0-100.0%
SG&A ExpensesN/A$5K$5K$8KN/AN/AN/AN/A
Operating IncomeN/A-$95K-$112K-$875KN/AN/AN/AN/A
EBITDAN/A-$95KN/AN/AN/AN/AN/AN/A
Interest ExpenseN/A$0$0-$69N/AN/A$0$0
Income TaxN/A$0$0$0N/A$0$0$0
Net IncomeN/A-$94K-$112K-$875KN/AN/AN/AN/A
EPS (Basic)-$0.01-2400.0%$0.00$0.00-$0.04$0.00+92.0%$0.00$0.00$0.00
EPS (Diluted)-$0.01$0.00$0.00-$0.04$0.00+92.0%$0.00$0.00$0.00
Diluted Shares (Avg)N/A44M44M20MN/A20M0.0%20M0.0%20M0.0%

Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit.

PAXH Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

PAXH quarterly balance sheet
MetricQ4'2610-KQ3'2610-QQ2'2610-QQ1'2610-Q/AQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-Q/A
Total Assets$584K$443K+14759233.3%$144K+86952.1%$1.2M+115028400.0%$0-100.0%$3-99.7%$165-91.2%$1-99.7%
Current Assets$1K$57K+1910900.0%$14K+8291.5%$490K+49028400.0%$0-100.0%$3-99.7%$165-91.2%$1-99.7%
Cash & Equivalents$1K$57K+1910900.0%$14K+8291.5%$130K+13028400.0%$0-100.0%$3-99.7%$165-91.2%$1-99.7%
Short-Term Investments$0$0$0$0$0$0$0$0
Long-Term Investments$0$0$0$0$0$0$0$0
Total Liabilities$967K-58.7%$807K-66.7%$769K-68.2%$1.8M-26.7%$2.3M-2.3%$2.4M+1.3%$2.4M+1.3%$2.4M+2.7%
Current Liabilities$967K-58.7%$807K-66.8%$769K-68.2%$723K-69.9%$2.3M-2.3%$2.4M+1.5%$2.4M+1.3%$2.4M+2.7%
Non-Current Liabilities$0$0+100.0%$0$1.0M$0-$4K$0$0
Total Equity-$384K+83.6%-$364K+85.0%-$625K+74.1%-$608K+74.7%-$2.3M+2.3%-$2.4M-1.4%-$2.4M-1.3%-$2.4M-2.7%
Retained Earnings-$6.4M-22.3%-$6.2M-19.4%-$6.1M-17.9%-$6.1M-18.6%-$5.2M-1.6%-$5.2M-0.7%-$5.1M-0.6%-$5.1M-1.2%

Not reported in any period shown, so not listed: Inventory, Accounts Receivable, Goodwill, Long-Term Debt.

PAXH Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

PAXH quarterly cash flow statement
MetricQ4'2610-KQ3'2610-QQ2'2610-QQ1'2610-Q/AQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-Q/A
Operating Cash Flow-$13K+30.0%$5K-$39K-$75K-$18KN/AN/AN/A
Depreciation & AmortizationN/A$0N/AN/AN/A$0N/AN/A
Capital Expenditures$114K$137KN/AN/A$0$0N/AN/A
Free Cash Flow-$126K-605.9%-$132KN/AN/A-$18KN/AN/AN/A
Investing Cash Flow-$114K-$137K-$71K$0$0$0$0$0
Financing Cash Flow$68K+331.8%$176K-$3K$205K$16KN/AN/AN/A

Not reported in any period shown, so not listed: Stock-Based Compensation, Dividends Paid, Share Buybacks.

PAXH Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

PAXH quarterly financial ratios
MetricQ4'2610-KQ3'2610-QQ2'2610-QQ1'2610-Q/AQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-Q/A
Return on AssetsN/A-21.3%-77.8%-76.1%N/AN/AN/AN/A
Current Ratio0.000.0x0.07+0.1x0.020.0x0.68+0.7x0.000.0x0.000.0x0.000.0x0.000.0x
Asset TurnoverN/A0.000.0x0.000.0x0.000.0xN/A0.000.0x0.000.0x0.000.0x

Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Return on Equity, Debt-to-Equity, FCF Margin.

Note: Shareholder equity is negative (-$384K), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Note: The current ratio is below 1.0 (0.00), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Frequently Asked Questions

What is PREAXIA HEALTH CARE PYMNT's annual revenue?

PREAXIA HEALTH CARE PYMNT (PAXH) reported $0 in total revenue for fiscal year 2026. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

Is PREAXIA HEALTH CARE PYMNT profitable?

No, PREAXIA HEALTH CARE PYMNT (PAXH) reported a net income of -$1.2M in fiscal year 2026.

What is PREAXIA HEALTH CARE PYMNT's earnings per share (EPS)?

PREAXIA HEALTH CARE PYMNT (PAXH) reported diluted earnings per share of -$0.03 for fiscal year 2026. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

PREAXIA HEALTH CARE PYMNT (PAXH) had EBITDA of -$976K in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization.

PREAXIA HEALTH CARE PYMNT (PAXH) recorded an outflow of $443K in free cash flow during fiscal year 2026. This represents a -966.4% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

PREAXIA HEALTH CARE PYMNT (PAXH) recorded an outflow of $121K in operating cash flow during fiscal year 2026, representing cash used by core business activities.

PREAXIA HEALTH CARE PYMNT (PAXH) had $584K in total assets as of fiscal year 2026, including both current and long-term assets.

PREAXIA HEALTH CARE PYMNT (PAXH) invested $322K in capital expenditures during fiscal year 2026, funding long-term assets and infrastructure.

PREAXIA HEALTH CARE PYMNT (PAXH) invested $308K in research and development during fiscal year 2026.

PREAXIA HEALTH CARE PYMNT (PAXH) had 48M shares outstanding as of fiscal year 2026.

PREAXIA HEALTH CARE PYMNT (PAXH) had a current ratio of 0.00 as of fiscal year 2026, which is below 1.0, which may suggest potential liquidity concerns.

PREAXIA HEALTH CARE PYMNT (PAXH) had a return on assets of -199.0% for fiscal year 2026, measuring how efficiently the company uses its assets to generate profit.

At the end of fiscal year 2026, PREAXIA HEALTH CARE PYMNT (PAXH) held $1K in cash, cash equivalents and investments, and reported an operating cash outflow of $121K over that year. Dividing the one by the other, the reported balance equals about 0 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.

PREAXIA HEALTH CARE PYMNT (PAXH) has negative shareholder equity of -$384K as of fiscal year 2026, so no debt-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

PREAXIA HEALTH CARE PYMNT (PAXH) reported a net loss of $1.2M while operations used $121K of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

PREAXIA HEALTH CARE PYMNT (PAXH) reported an operating loss of $993K against $326 in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Back to top